SPOTLIGHT: The best pharma stocks of 2007

 
When it comes to picking stocks, prediction may be murky, but hindsight is crystal clear. We looked at every company in the Wall Street Journal's pharma sector (plus a few others of our own choice), comparing their stock prices on January 1 and December 31, 2007. Then we ranked those companies by percentage increase in stock price. If we'd had the same info at the beginning of last year, these are the 15 stocks we would have chosen. Check out this list of the best pharma stocks of 2007. Report

Suggested Articles

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.